Association between cognitive impairment and urinary dysfunction in Parkinson's disease

J Neural Transm (Vienna). 2017 May;124(5):543-550. doi: 10.1007/s00702-017-1690-2. Epub 2017 Feb 17.

Abstract

Urinary dysfunction (UD) is a common non-motor feature of Parkinson's disease (PD), and might be secondary to neurodegeneration involving cortical and subcortical brain areas. The possible link between UD and cognitive deficits has never been examined in frontal cortex impairment, and is still not completely understood in PD. In the present study, 94 PD patients underwent a comprehensive motor, cognitive and non-motor assessment. It was shown that 55.3% of patients reported UD, of which 17% needed specific urological treatment. Patients who reported UD performed worse on global cognition (PANDA, p = .05), visuo-constructive functions (CERAD/praxis, p = .03; and Figure Test, p = .03), and instrumental activities of daily living functions (IADL, p = .03), than patients without UD. The group with UD medication performed worse on global cognition (PANDA, p = .02) and visuo-constructive functions (CERAD/praxis, p = .05; CERAD/praxis recall, p = .05) than the UD group without medication, independent of anticholinergic treatment effect. Our findings suggest an association between cognitive impairment and UD in PD independent from symptomatic treatment.

Keywords: Bladder dysfunction; Cognition; Dementia; Neuropsychology; Parkinson’s disease; Urge incontinence.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Aged
  • Aged, 80 and over
  • Antiparkinson Agents / therapeutic use
  • Cognitive Dysfunction / complications*
  • Cohort Studies
  • Female
  • Humans
  • Male
  • Middle Aged
  • Neuropsychological Tests
  • Parkinson Disease / complications*
  • Parkinson Disease / drug therapy
  • Parkinson Disease / psychology*
  • Self Report
  • Urination Disorders / complications*
  • Urination Disorders / drug therapy
  • Urination Disorders / psychology
  • Urological Agents / therapeutic use

Substances

  • Antiparkinson Agents
  • Urological Agents